Atlas Trials

P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome

Clinical trial NCT01886287 · TERMINATED

Trial details

NCT number
NCT01886287
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Carcinoma
Start date
2013-12-01
Primary completion
2014-08-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.